![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 30, 2016 12:27:11 AM
Phase III results for Meloxicam are due to be reported in both the third and fourth quarter of this year.
If positive - and there is NO reason to think they will not be - this stock will see new highs relatively quickly.
Meloxicam if approved next year, should give the company a 500 million dollar market cap. Right now it stands at a mere $75 million so upside for the next 12 months is over 500%. Not sure if the 500 million market cap would be realized immediately upon approval or not - probably would take a bit longer, but once meloxicam begins to grab a market share, the market cap will rise significantly.
Maybe 500% within a year is too high, but certainly will be 3-4X with FDA approval which could come in a year.
Now is the time to get in!
I am long REPH, although my position is small. Wish I had a lot of free funds to invest. Oh well. Start where you are at and build.
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM